Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects
- PMID: 19493067
- DOI: 10.1111/j.1748-720X.2009.00366.x
Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects
Abstract
This manuscript addresses how developing countries can maximize access to essential medicines and minimize unwanted side-effects within the legal environment of a compulsory license regime. While compulsory licensing can play a role in improving public health, external social and political conditions must be considered in order to make licensing an effective practice.
Similar articles
-
Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules.J Law Med Ethics. 2009 Summer;37(2):222-39. doi: 10.1111/j.1748-720X.2009.00367.x. J Law Med Ethics. 2009. PMID: 19493068
-
An economic justification for open access to essential medicine patents in developing countries.J Law Med Ethics. 2009 Summer;37(2):184-208. doi: 10.1111/j.1748-720X.2009.00365.x. J Law Med Ethics. 2009. PMID: 19493066
-
Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options.J Law Med Ethics. 2009 Summer;37(2):247-63. doi: 10.1111/j.1748-720X.2009.00369.x. J Law Med Ethics. 2009. PMID: 19493070 Free PMC article.
-
Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries.Appl Health Econ Health Policy. 2017 Oct;15(5):557-565. doi: 10.1007/s40258-017-0306-1. Appl Health Econ Health Policy. 2017. PMID: 28120166 Review.
-
Therapeutic drug use in Bangladesh: policy versus practice.Indian J Med Ethics. 2008 Jan-Mar;5(1):24-5. doi: 10.20529/IJME.2008.009. Indian J Med Ethics. 2008. PMID: 18630250 Review.
Cited by
-
Access to medications and conducting clinical trials in LMICs.Nat Rev Nephrol. 2015 Mar;11(3):189-94. doi: 10.1038/nrneph.2015.6. Epub 2015 Feb 10. Nat Rev Nephrol. 2015. PMID: 25668002 Review.
-
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis.Global Health. 2019 Jun 27;15(1):42. doi: 10.1186/s12992-019-0485-7. Global Health. 2019. PMID: 31248441 Free PMC article.
-
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences.Appl Health Econ Health Policy. 2025 Jul;23(4):613-624. doi: 10.1007/s40258-025-00956-x. Epub 2025 Apr 19. Appl Health Econ Health Policy. 2025. PMID: 40252156 Review.
-
The Legislative Approach and System Improvement of China's Compulsory Licensing for Drug Patents.Drug Des Devel Ther. 2021 Sep 1;15:3717-3731. doi: 10.2147/DDDT.S324148. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34511881 Free PMC article.
-
Access to cancer medications in low- and middle-income countries.Nat Rev Clin Oncol. 2013 Jun;10(6):314-22. doi: 10.1038/nrclinonc.2013.55. Epub 2013 Apr 9. Nat Rev Clin Oncol. 2013. PMID: 23568416 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical